PHAR CIK: 1828316

Pharming Group N.V.

  • Netherlands
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
37.8
FY22:
22.5
FY23:
−17.3
FY24:
−1.80
FY25:
54.7
Change from FY21 to FY25
millions USD
FY21:
−21.3
FY22:
5.32
FY23:
−129
FY24:
31.6
FY25:
26.3
Change from FY21 to FY25
millions USD
FY21:
−27.9
FY22:
−4.98
FY23:
−1.04
FY24:
−34.4
FY25:
1.50
millions USD
FY21:
−11.4
FY22:
22.8
FY23:
−148
FY24:
−4.59
FY25:
82.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
27.1
FY22:
21.1
FY23:
−18.7
FY24:
−2.59
FY25:
54.0

All amounts in millions USD Data source:SEC EDGAR